In A Nutshell

Your Reliable Partner In Early Phase

Company Background
CRS was established in 2006 as a merger of three German Phase-I CROs having more than 40 years of experience in clinical pharmacology. As of today, CRS comprises 4 Clinical Pharmacology Units (CPUs) in Germany with a total bed capacity of more than 200 beds. This makes CRS to one of the leading European provider of Phase-I services, including standard PK/PD trial designs as well as special fields of expertise in a strictly standardised Phase-I environment.

Besides the standard Early Phase studies in healthy volunteers, a substantial part of CRS's business is the conduct of patient driven trials as well as multicentre trials. Clients from various sectors of the healthcare industry (ranging from pharmaceutical & biotech to developers of medicinal products, nutritionals and cosmetics) profit from the comprehensive service portfolio offered by CRS.

Comprehensive Service Portfolio

  • Consultancy
  • Project Management
  • Clinical Conduct
  • Monitoring
  • Quality Assurance
  • Clinical Trial Supply Management
  • Laboratory / Bioanalytical Services by external partners
  • Clinical Data Management
  • Statistics by external partners
  • Medical Writing

In the following we offer you further information about CRS e.g. 'special fields of expertise' and 'large pool of volunteers and patients'. Please feel free to contact CRS directly.

Special Fields of Expertise
  • Interaction trials (food, drug & genotype)
  • Thorough QT / QTc
  • Renal & hepatic impairment
  • Respiratory / inhalative devices
  • Women's health / gynaecological examinations
  • Men's health
  • Dermal & transdermal application
  • Skin safety, sensitisation & photo-toxicity
  • Opioids
Large Pool of Volunteers and Patients
  • Male & female
  • Different age groups (incl. 85 years and over)
  • Women of childbearing potential / postmenopausal
  • Allergies
  • Renal & hepatic impairment
  • Cardiovascular
  • Diabetes
  • Asthma & COPD
  • Inflammatory diseases